RELEASE OF PROSTACYCLIN IN VIVO AND ITS ROLE IN MAN
- 1 February 1983
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 321 (8320), 317-319
- https://doi.org/10.1016/s0140-6736(83)91626-4
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- The simultaneous analysis of prostanoids in biological fluids by combined capillary column gas chromatography and negative-ion chemical-ionization mass spectrometryBiochemical Society Transactions, 1982
- Inhibition of vascular epoprostenol (prostacyclin, PGI2) production in vitro by plasma from healthy subjects and patients with severe renal impairment.British Journal of Clinical Pharmacology, 1982
- Analysis of picomolar concentrations of 6-oxo-prostaglandin F1 in biological fluidsJournal of Chromatography A, 1982
- Prostacyclin is not a circulating hormone in manProstaglandins, 1982
- The time course and magnitude of prostacyclin (PGI2) production by rat aortic rings incubated in human plasmaBiochemical Pharmacology, 1982
- Prostacyclin binding to guinea pig pulmonary receptorsEuropean Journal of Pharmacology, 1981
- On the occurrence of prostacyclin metabolites in plasma and vascular tissue as determined radioimmunologicallyFEBS Letters, 1980
- A double blind placebo controlled crossover study of prostacyclin in manLife Sciences, 1979
- Selective Binding Site for [3H]Prostacyclin on PlateletsJCI Insight, 1979
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976